“The Not-So-Standard Model: Reconsidering Agency-Head Review of Administrative Adjudication Decisions”
Nina A. Mendelson Rebecca S. Eisenberg- Administrative Law
Administrative Law Review
2023
“New Innovation Models in Medical AI”
Nicholson Price Rebecca S. Eisenberg- Law and Technology
- Health Law
Washington University Law Review
2022
“Limiting Agency Head Review in the Design of Administrative Adjudication”
Nina A. Mendelson Rebecca S. Eisenberg- Administrative Law
Yale Journal of Regulation: Notice and Comment
2022
“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Iowa Law Review
2019
“Opting Into Device Regulation in the Face of Uncertain Patentability”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
- Law and Technology
Marquette Intellectual Property Law Review
2019
“Cannabis for Medical Use: FDA and DEA Regulation in the Hall of Mirrors”
Rebecca S. Eisenberg- Health Law
Food and Drug Law Journal
2019
“Shifting Institutional Roles in Biomedical Innovation in a Learning Healthcare System”
Rebecca S. Eisenberg- Law and Technology
- Health Law
Journal of International Economics
2018
“Universities: The Fallen Angels of Bayh-Dole?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Daedalus
2018
Science
2017
“Diagnostics Need Not Apply”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
- Law and Technology
Boston University Journal of Science & Technology Law
2015
“Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents”
Rebecca S. Eisenberg Daniel A. Crane- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2015
“Prometheus Rebound: Diagnostics, Nature, and Mathematical Algorithms”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Yale Law Journal Online
2013
“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012
“Patent Costs and Unlicensed Use of Patented Inventions”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
University of Chicago Law Review
2011
“Pharma’s Nonobvious Problem”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Lewis and Clark Law Review
2008
“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Houston Law Review
2008
“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007
“The Role of the FDA in Innovation Policy”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2007
“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006
“BioTech. Patents: Looking Backward While Moving Forward”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Nature Biotechnology
2006
“Patents and Data-Sharing in Public Science”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Industrial and Corporate Change
2006
“Learning the Value of Drugs - Is Rofecoxib a Regulatory Success Story?”
Rebecca S. Eisenberg- Health Law
New England Journal of Medicine
2005
Yale Journal of Health Policy, Law, and Ethics
2005
“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004
“Reexamining Drug Regulation from the Perspective of Innovation Policy”
Rebecca S. Eisenberg- Health Law
Journal of Institutional and Theoretical Economics
2004
“Bayh-Dole Reform and the Progress of Biomedicine”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
American Scientist
2003
“Patenting Genome Research Tools and the Law”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Comptes rendus Biologies
2003
Science
2003
“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Fordham Law Review
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Law and Contemporary Problems
2003
“Public vs. Proprietary Science: A Fruitful Tension?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Daedalus
2002
“Public vs. Proprietary Science: A Fruitful Tension?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002
“Why the Gene Patenting Controversy Persists”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002
“The Shifting Functional Balance of Patents and Drug Regulation”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Health Affairs
2001
“Genomics in the Public Domain: Strategy and Policy”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Nature Reviews Genetics
2000
“The Promise and Perils of Strategic Publication to Create Prior Art: A Response to Professor Parchomovsky”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Michigan Law Review
2000
“Analyze This: A Law and Economics Agenda for the Patent System”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Vanderbilt Law Review
2000
“Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Emory Law Journal
2000
“National Policy Perspectives-Streamlining the Transfer of Research Tools”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
1999
“Can Patents Deter Innovation? The Anticommons on Biomedical Research”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Science
1998
“Upstream Patents = Downstream Bottlenecks”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Law Quadrangle Notes
1998
Trends in Genetics
1998
“Focus on Faculty - Rebecca S. Eisenberg”
Rebecca S. Eisenberg
Law Quadrangle Notes
1998
“Structure and Function in Gene Patenting”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Nature Genetics
1997
“Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Virginia Law Review
1996
“Intellectual Property at the Public-Private Divide: The Case of Large-Scale cDNA Sequencing”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
University of Chicago Law School Roundtable
1996
“Intellectual Property Issues in Genomics”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Trends in Biotechnology
1996